Integer (NYSE:ITGR) PT Raised to $140.00

Integer (NYSE:ITGR) had its price target raised by Benchmark from $130.00 to $140.00 in a report released on Monday, Benzinga reports. Benchmark currently has a buy rating on the medical equipment provider’s stock.

Several other analysts have also recently issued reports on ITGR. Oppenheimer started coverage on shares of Integer in a research report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price target on the stock. KeyCorp increased their price target on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. Bank of America raised their target price on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Citigroup raised their target price on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a report on Tuesday, October 1st. Finally, Truist Financial raised their target price on shares of Integer from $145.00 to $150.00 and gave the company a “buy” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $140.14.

Integer Trading Up 0.2 %

NYSE:ITGR opened at $126.84 on Monday. Integer has a one year low of $69.40 and a one year high of $133.53. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. The firm has a market cap of $4.25 billion, a P/E ratio of 43.86, a P/E/G ratio of 1.86 and a beta of 1.08. The firm has a 50-day simple moving average of $127.37 and a 200-day simple moving average of $120.86.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.27 EPS. Equities analysts anticipate that Integer will post 5.3 EPS for the current fiscal year.

Insider Buying and Selling at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the transaction, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 2.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Integer

Several large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in Integer by 0.6% during the first quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock worth $446,428,000 after acquiring an additional 23,382 shares during the period. Earnest Partners LLC grew its holdings in Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after acquiring an additional 37,340 shares during the period. Driehaus Capital Management LLC boosted its position in shares of Integer by 62.5% in the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after purchasing an additional 135,750 shares during the period. Tributary Capital Management LLC boosted its position in shares of Integer by 0.3% in the 2nd quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after purchasing an additional 772 shares during the period. Finally, Envestnet Asset Management Inc. boosted its position in shares of Integer by 0.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 259,830 shares of the medical equipment provider’s stock valued at $30,086,000 after purchasing an additional 1,941 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.